Contact
Please use this form to send email to PR contact of this press release:
Development Data for mRNA & Small Molecule Immunotherapies for Treating Cancer: Regen BioPharma,: Stock Symbol: RGBP
TO:
David R. Koos, Ph.D.
Regen BioPharma Inc.
+1 619-722-5505